AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0062
+0.0006 (10.71%)
Apr 29, 2026, 10:16 AM EST
AXIM Biotechnologies Employees
As of December 31, 2023, AXIM Biotechnologies had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
$13,271
Profits / Employee
-$590,839
Market Cap
2.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Clearside Biomedical | 32 |
| Avenue Therapeutics | 1 |
| Mosaic ImmunoEngineering | 8 |
| ZyVersa Therapeutics | 7 |
| Vaccinex | 27 |
| Vaxxinity | 65 |
AXIM Biotechnologies News
- 2 years ago - VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production - GlobeNewsWire
- 2 years ago - AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease - Business Wire
- 2 years ago - AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test - Business Wire
- 3 years ago - Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 3 years ago - AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 3 years ago - AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch - GlobeNewsWire